Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HIKAL. vs PARMAX PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    HIKAL. PARMAX PHARMA HIKAL./
PARMAX PHARMA
 
P/E (TTM) x 32.2 85.6 37.6% View Chart
P/BV x 3.5 2.1 166.8% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 HIKAL.   PARMAX PHARMA
EQUITY SHARE DATA
    HIKAL.
Mar-21
PARMAX PHARMA
Mar-21
HIKAL./
PARMAX PHARMA
5-Yr Chart
Click to enlarge
High Rs20452 392.7%   
Low Rs6715 441.4%   
Sales per share (Unadj.) Rs139.551.3 272.1%  
Earnings per share (Unadj.) Rs10.81.5 730.4%  
Cash flow per share (Unadj.) Rs17.75.3 335.1%  
Dividends per share (Unadj.) Rs2.000-  
Avg Dividend yield %1.50-  
Book value per share (Unadj.) Rs75.711.4 663.6%  
Shares outstanding (eoy) m123.305.10 2,417.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.00.7 148.3%   
Avg P/E ratio x12.622.7 55.3%  
P/CF ratio (eoy) x7.76.4 120.5%  
Price / Book Value ratio x1.82.9 60.8%  
Dividend payout %18.50-   
Avg Mkt Cap Rs m16,738172 9,759.0%   
No. of employees `000NANA-   
Total wages/salary Rs m1,64336 4,595.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m17,204262 6,578.9%  
Other income Rs m501 5,597.8%   
Total revenues Rs m17,254262 6,575.5%   
Gross profit Rs m3,22934 9,449.4%  
Depreciation Rs m85219 4,389.5%   
Interest Rs m3624 10,168.0%   
Profit before tax Rs m2,06412 17,088.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7335 16,142.1%   
Profit after tax Rs m1,3318 17,657.8%  
Gross profit margin %18.813.1 143.6%  
Effective tax rate %35.537.6 94.5%   
Net profit margin %7.72.9 268.3%  
BALANCE SHEET DATA
Current assets Rs m9,251103 8,947.9%   
Current liabilities Rs m7,033112 6,253.8%   
Net working cap to sales %12.9-3.5 -372.1%  
Current ratio x1.30.9 143.1%  
Inventory Days Days265 526.7%  
Debtors Days Days10323,089,062 0.0%  
Net fixed assets Rs m10,906112 9,737.3%   
Share capital Rs m24745 554.0%   
"Free" reserves Rs m9,08714 66,477.1%   
Net worth Rs m9,33458 16,043.3%   
Long term debt Rs m2,62954 4,838.7%   
Total assets Rs m20,157227 8,868.8%  
Interest coverage x6.74.4 152.6%   
Debt to equity ratio x0.30.9 30.2%  
Sales to assets ratio x0.91.2 74.2%   
Return on assets %8.44.9 172.0%  
Return on equity %14.313.0 110.0%  
Return on capital %20.313.9 145.9%  
Exports to sales %68.70-   
Imports to sales %26.90-   
Exports (fob) Rs m11,823NA-   
Imports (cif) Rs m4,623NA-   
Fx inflow Rs m11,8230-   
Fx outflow Rs m4,6234 122,626.8%   
Net fx Rs m7,200-4 -190,970.6%   
CASH FLOW
From Operations Rs m2,29035 6,497.0%  
From Investments Rs m-1,562-31 4,964.9%  
From Financial Activity Rs m-9694 -24,217.0%  
Net Cashflow Rs m-2408 -3,086.8%  

Share Holding

Indian Promoters % 68.8 30.8 223.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.8 0.0 -  
FIIs % 3.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 31.2 69.2 45.1%  
Shareholders   79,105 1,590 4,975.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare HIKAL. With:   SUN PHARMA    LUPIN    DR. REDDYS LAB    CIPLA    AUROBINDO PHARMA    



Today's Market

Sensex Trades Flat; Energy and Oil and Gas Sector Rally(10:30 am)

Asian share markets were trading on a mixed note this morning. The Nikkei surged 2.4% while the Hang Seng was down by 0.1%. The Shanghai Composite was trading higher by 0.1%.